(Q28261835)

12 December 2020

Short- and long-term (six-year) hemodynamic effects of labetalol in essential hypertension.

1 reference

12 December 2020

Haemodynamic effects of nifedipine in essential hypertension at rest and during exercise.

1 reference

12 December 2020

Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects.

1 reference

12 December 2020

The place of alpha-adrenoceptor and beta-adrenoceptor blockade in the treatment of hypertension

1 reference

12 December 2020

Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoreceptor blockade by labetalol

1 reference

12 December 2020

Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension

1 reference

12 December 2020

Labetalol: the nineteen-eighties

1 reference

12 December 2020

Prizidilol in essential hypertension: long-term effects on plasma volume, extracellular fluid volume, and central hemodynamics at rest and during exercise

1 reference

12 December 2020

Haemodynamic effects of long-term oral labetalol

1 reference

12 December 2020

Renal haemodynamics after chronic treatment with labetalol and propranolol

1 reference

12 December 2020

Vasodilator drugs in the treatment of hypertension

1 reference

12 December 2020

Intravenous labetalol in the treatment of severe hypertension

1 reference

12 December 2020

Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings

1 reference

12 December 2020

Response of the systemic and pulmonary circulation to alpha- and beta-receptor blockade (labetalol) at rest and during exercise in hypertensive patients

1 reference

12 December 2020

Haemodynamic effects of pindolol in hypertensive patients

1 reference

12 December 2020

Comparison of labetalol with other anti-hypertensive drugs

1 reference

12 December 2020

Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension

1 reference

12 December 2020

Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent

1 reference

12 December 2020

The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels

1 reference

12 December 2020

A review of the haemodynamic effects of labetalol in man.

1 reference

12 December 2020

Response of the systemic pulmonary circulation to labetalol at rest and during exercise

1 reference

12 December 2020

Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations

1 reference

12 December 2020

Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol.

1 reference

12 December 2020

Role of beta-adrenergic blockade in the therapy of patients with myocardial infarction

1 reference

12 December 2020

Intravenous labetalol in severe hypertension

1 reference

12 December 2020

Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise

1 reference

12 December 2020

Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease.

1 reference

12 December 2020

Physiological aspects of primary hypertension

1 reference

12 December 2020

Labetalol: a review of its pharmacology and therapeutic use in hypertension

1 reference

12 December 2020

Hemodynamic consequences of long-term beta-blocker therapy: a 5-year follow-up study of atenolol

1 reference

12 December 2020

Haemodynamic long-term effects of prazosin plus tolamolol in essential hypertension

1 reference

12 December 2020

Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects

1 reference

12 December 2020

Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension

1 reference

12 December 2020

Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension

1 reference

12 December 2020

Labetalol (AH5158), a Competitive Alpha-and Beta-Receptor Blocking Drug, in the Management of Hypertension

1 reference

12 December 2020

Acute Hemodynamic Effects of Labetalol in Severe Hypertension

1 reference

12 December 2020

Treatment of severe hypertension by repeated bolus injections of labetalol

1 reference

12 December 2020